glp 1 gut microbiome A Specific Microbiota Dysbiosis of Type 2 Diabetic Mice Induces GLP-1 Resistance through an Enteric NO-Dependent and Gut-Brain Axis Mechanism: Cell Metabolism Interplay of gut microbiota, glucagon-like
Description
Adult people (18 years) with a diagnosis of obesity (body mass index30 kg/m2) or T2DM (ICD-10-CM: E11) between 2018 and 2024 were subdivided in two mutually exclusive cohorts: (1) GLP-1 RA Users

The researchers analyzed data from a large, multi-institutional medical records database, including 73,483 adults taking GLP-1sincluding Semaglutide drugs like Ozempic & Wegovy, as well as Victoza (Liraglutide), Trulicity (Dulaglutide), or Byetta (Exenatide)and compared them with the same number of adults not taking the medications, tracking health outcomes for five years after treatment began

We aimed to e...
PMID: 33680978

Learn what to share with your patients.
